A Single Platelet-Rich Plasma Injection for Chronic Midsubstance Achilles Tendinopathy
A Single Platelet-Rich Plasma Injection for Chronic Midsubstance Achilles Tendinopathy
复制标题
单次富血小板血浆注射治疗慢性中质跟腱病
DOI：
10.1177/1938640014532129
复制
发表时间：
2014
影响因子：
--
通讯作者：
J. Kennedy
中科院分区：
文献类型：
--
作者：
C. Murawski;N. Smyth;Hunter Newman;J. Kennedy
本研究的目的是评估一系列接受单次富血小板血浆（PRP）注射治疗慢性中质跟腱病的患者，这些患者保守治疗失败。32例患者接受单次PRP注射治疗慢性中物质跟腱病，并在6个月的最后随访中使用足踝结局评分和简短的12一般健康问卷进行评估。所有患者在注射前和注射后6个月进行磁共振成像。32名患者中有25名（78%）报告他们在6个月的随访中无症状，并且能够参加各自的运动和日常活动。其余7例（22%）患者报告症状在6个月后没有改善，最终需要手术治疗。4名患者继续进行跟腱镜检查，另外3名患者通过肌腱劈裂方法进行开放性清创。一项对接受单次PRP注射治疗慢性跟腱中物质病变的患者的回顾性评估显示，在6个月的随访中，78%的患者临床改善，避免了手术干预。证据级别：治疗性，IV级：回顾性病例系列
The purpose of this study was to evaluate a series of patients undergoing a single platelet-rich plasma (PRP) injection for the treatment of chronic midsubstance Achilles tendinopathy, in whom conservative treatment had failed. Thirty-two patients underwent a single PRP injection for the treatment of chronic midsubstance Achilles tendinopathy and were evaluated at a 6-month final follow-up using the Foot and Ankle Outcome Score and Short Form 12 general health questionnaire. Magnetic resonance imaging was performed on all patients prior to and 6 months after injection. Twenty-five of 32 patients (78%) reported that they were asymptomatic at the 6-month follow-up visit and were able to participate in their respective sports and daily activities. The remaining 7 patients (22%) who reported symptoms that did not improve after 6 months ultimately required surgery. Four patients went on to have an Achilles tendoscopy, while the other 3 had an open debridement via a tendon splitting approach. A retrospective evaluation of patients receiving a single PRP injection for chronic midsubstance Achilles tendinopathy revealed that 78% had experienced clinical improvement and had avoided surgical intervention at 6-month follow-up. Levels of Evidence: Therapeutic, Level IV: Retrospective case series